Navigation Links
Reportlinker Adds Cancer Vaccines Markets
Date:4/26/2011

Business Landscape 93

9.1 Technology and Market Trends 93

9.2 M&A Activity 94

9.3 Partnering 94

9.4 Competitive Situation 96

9.5 Intellectual Property Rights 97

9.6 Industry Challenges and Strategic Recommendations for Commercialization 98

9.7 Opportunities and Strategic Recommendations 99

9.8 Requirements for a Successful Cancer Vaccine Products Industry 102

10. Company Profiles 106

10.1 Advaxis 106

10.2 Agenus (formerly Antigenics) 106

10.3 AlphaVax 106

10.4 Antigen Express 107

10.5 Apthera 107

10.6 Argos Therapeutics 107

10.7 AVAX Technologies 107

10.8 Bavarian Nordic 108

10.9 Bellicum Pharmaceuticals 108

10.10 BioSante Pharmaceuticals 108

10.11 Biovest International 108

10.12 Celldex Therapeutics 109

10.13 CG Therapeutics 109

10.14 CureVac 109

10.15 DanDrit Biotech 109

10.16 Dendreon 110

10.17 EMD Serono 110

10.18 Geron 110

10.19 GlaxoSmithKline 110

10.20 GlobeImmune 111

10.21 Immatics Biotechnologies 111

10.22 ImmunoCellular Therapeutics 111

10.23 Immunovaccine 111

10.24 Inovio Pharmaceuticals 111

10.25 KAEL-Gemvax 112

10.26 MannKind 112

10.27 Mologen AG 112

10.28 NewLink Genetics Corporation 112

10.29 Northwest Biotherapeutics 113

10.30 NovaRx 113

10.31 Oxford BioMedica 113

10.32 Prima BioMed 113

10.33 Scancell 113

10.34 Transgene 113

10.35 Trimed Biotech 114

10.36 Vaccinogen 114

10.37 Vical 114

INDEX OF FIGURES

Figure 2.1: Estimates of National Expenditures for Cancer Care in 2006 by Cancer

Site 14

Figure 2.2: Person-Years of Life Lost (PYLL) in the U.S. Due to Cancer, Male,

2006 15

Figure 2.3: Person-Years of Life Lost (PYLL) in the U.S. Due to Cancer, Female,

2006 16

Fig
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... JUPITER, Fla. , Aug. 3, 2015 /PRNewswire/ ... announced initiation of its second clinical development program ... drug candidate, CL-H1T.  CL-H1T contains ... is being developed as a treatment for migraine ... "Many patients with migraine headaches ...
(Date:8/3/2015)... and FLORHAM PARK, N.J. , ... once-daily naldemedine met its primary and secondary endpoints in ... of opioid-induced constipation (OIC) in adult patients with chronic ... mu-opioid receptor antagonist (PAMORA). This is the third Phase ... key secondary endpoints. Study results showed that ...
(Date:8/3/2015)... ZIONA, Israel , August 3, 2015 /PRNewswire/ ... today announced it received the statistical analysis of results from ... administered in the BVX-005 phase II trial which took place ... which did not exist at the time of the study- ... that caused the epidemic in the United States ...
Breaking Medicine Technology:Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
(Date:8/3/2015)... ... August 03, 2015 , ... ... 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright Bulb B2B Awards ... brands. BESLER Consulting's campaign for the launch of their Readmissions Analytics product was ...
(Date:8/3/2015)... ... 03, 2015 , ... To date, many pharmaceutical and biotech ... of benefits, allowing them to gain access to capabilities that cannot be found ... resources, get access to innovation and ensure timely introduction of product into the ...
(Date:8/3/2015)... ... August 03, 2015 , ... A recent survey by ... of Hispanics believe people can positively affect their diabetes, few look beyond diet ... making diet changes was important. Far fewer participants mentioned the need for exercise ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... and the largest online retailer of nutritional supplements, has officially opened the ... for 11 awards in the following categories:, ,     Brand ...
(Date:8/3/2015)... Venice Beach, CA (PRWEB) , ... August 03, ... ... supporting individuals suffering from ALS and amputation , AUGUST 3, 2015 – Since ... DIY category in March 2015, Not Impossible – an organization whose mission is ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4
... Kentucky Ranks 47th Nationwide in Health Status; Anthem Blue ... services to more than 5,000, Kentuckians located in ... LOUISVILLE, Ky., Nov. 14 Anthem Blue Cross and ... program that,incorporates public health data to identify and help ...
... in with a strong,70% Omega-3 fatty acid content, ... formula, is now available in convenient,smaller-sized soft gels. ... same exceptionally high concentrated oil as Ultimate Omega, ... swallowing. Ideal for ages 5,through adult, the all ...
... FORT MYERS, Fla., Nov. 14 NeoGenomics, Inc.,(OTC Bulletin ... its results for the third quarter of FY 2007.,Significant ... nine,months of the year included the following: Third ... revenues in Q3 07 vs. Q3 06 -- ...
... Ill., Nov. 14 Delta Dental, the nation,s,largest ... Readers,Choice Award from Benefits Selling magazine as the ... and network availability. The,awards were announced in the ... Selling surveys its readers annually, asking them to ...
... reporting the first successful strategy to reduce smokers nicotine ... study provides strong support for proposals now being considered ... according to the research team. , The key to ... of gradually decreasing nicotine content over a number of ...
... 14 On the first United Nations World,Diabetes ... to develop national policies for the prevention, care ... to consider the need,for a diabetes global fund ... at the World Diabetes Day press conference, Dr ...
Cached Medicine News:Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 2Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 3Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 4Health News:Nordic Naturals Introduces Ultimate Omega 500 - Their Best Selling Formula Now Available in a Smaller Size Soft Gel! 2Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 2Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 3Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 4Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 5Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 6Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 7Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 8Health News:Brokers Name Delta Dental the Best in Coverage, Plan Design and Networks 2Health News:Nicotine addiction slashed in test of new cigarette smoking strategy 2Health News:Nicotine addiction slashed in test of new cigarette smoking strategy 3Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 2Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 3Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: